Home RxNorm 1046771 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Levbid] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1046771
RxNorm name 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Levbid]
Display name LEVBID XR (Oral Pill)
Full name 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Levbid]
Term type SBD
Status Active
Strength 0.375 mg
Dose form 12 HR XR Tab
Route Oral Pill
Updated 2026-08-03 17:29:12 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 122010
Active start 122010
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength hyoscyamine sulfate 0.375 MG / 1 EACH hyoscyamine hyoscyamine sulfate
Derived Ingredient Concepts# Ingredient, RxCUI table Ingredient RxCUI hyoscyamine 153970
FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 68220-115-10 68220-115 Levbid hyoscyamine sulfate Viatris Specialty LLC
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 15 matching rows.
NDC11, Source, Active table NDC11 Source Active 00247177206 rxnav_ndcs yes 00247177210 rxnav_ndcs yes 68220011510 rxnav_ndcs yes 00091353801 rxnav_historical 00091353805 rxnav_historical 00091353899 rxnav_historical 00131353801 rxnav_historical 00131353805 rxnav_historical 54868393900 rxnav_historical 54868393901 rxnav_historical 55154095101 rxnav_historical 58716092410 rxnav_historical 58716092450 rxnav_historical 62584001900 rxnav_historical 68220011550 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective eb13c96f-319a-46f4-9955-ef5fa0a5f110 Levbid 0.375 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Levbid] [SBD] · 12 HR Levbid 0.375 MG Extended Release Oral Tablet [SY] · Levbid (hyoscyamine sulfate 0.375 MG) 12 HR Extended Release Oral Tablet [SY] · Levbid 0.375 MG 12 HR Extended Release Oral Tablet [SY] 5 6 Levbid ® (hyoscyamine sulfate, 0.375 mg) extended-release tablets Rx Only 201090-01 115 Rev. 07/2025 20250715
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective eb13c96f-319a-46f4-9955-ef5fa0a5f110 Levbid ® (hyoscyamine sulfate, 0.375 mg) extended-release tablets Rx Only 201090-01 115 Rev. 07/2025 Viatris Specialty LLC 20250715
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC A03BA Belladonna alkaloids, tertiary amines ATC1-4 hyoscyamine MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine sulfate MEDRT D064692 Hyoscyamine CHEM has_ingredient hyoscyamine MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine sulfate MEDRT D000014 Abnormalities, Drug-Induced DISEASE may_treat hyoscyamine MEDRT D003085 Colic DISEASE may_treat hyoscyamine MEDRT D003085 Colic DISEASE may_treat hyoscyamine sulfate MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine MEDRT D003093 Colitis, Ulcerative DISEASE ci_with hyoscyamine sulfate MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine MEDRT D004342 Drug Hypersensitivity DISEASE ci_with hyoscyamine sulfate MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine MEDRT D018589 Gastroparesis DISEASE induces hyoscyamine sulfate MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine sulfate MEDRT D005901 Glaucoma DISEASE ci_with hyoscyamine MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine sulfate MEDRT D006945 Hyperhidrosis DISEASE may_treat hyoscyamine MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine MEDRT D007077 Ileal Diseases DISEASE ci_with hyoscyamine sulfate MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine MEDRT D007415 Intestinal Obstruction DISEASE ci_with hyoscyamine sulfate MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine MEDRT D007431 Intraoperative Complications DISEASE may_treat hyoscyamine sulfate MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine sulfate MEDRT D043183 Irritable Bowel Syndrome DISEASE may_treat hyoscyamine MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine MEDRT D008532 Megacolon, Toxic DISEASE ci_with hyoscyamine sulfate MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine MEDRT D009127 Muscle Rigidity DISEASE may_treat hyoscyamine sulfate MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine sulfate MEDRT D009157 Myasthenia Gravis DISEASE ci_with hyoscyamine MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine MEDRT D017202 Myocardial Ischemia DISEASE ci_with hyoscyamine sulfate MEDRT D010437 Peptic Ulcer DISEASE may_treat hyoscyamine MEDRT D010437 Peptic Ulcer DISEASE may_treat hyoscyamine sulfate MEDRT D012220 Rhinitis DISEASE may_treat hyoscyamine MEDRT D012220 Rhinitis DISEASE may_treat hyoscyamine sulfate MEDRT D012771 Shock, Hemorrhagic DISEASE ci_with hyoscyamine sulfate MEDRT D012771 Shock, Hemorrhagic DISEASE ci_with hyoscyamine MEDRT D012798 Sialorrhea DISEASE may_treat hyoscyamine sulfate MEDRT D012798 Sialorrhea DISEASE may_treat hyoscyamine MEDRT D013035 Spasm DISEASE may_treat hyoscyamine MEDRT D013035 Spasm DISEASE may_treat hyoscyamine sulfate MEDRT D014202 Tremor DISEASE may_treat hyoscyamine MEDRT D014202 Tremor DISEASE may_treat hyoscyamine sulfate MEDRT D014524 Urethral Obstruction DISEASE ci_with hyoscyamine MEDRT D014524 Urethral Obstruction DISEASE ci_with hyoscyamine sulfate MEDRT D001750 Urinary Bladder, Neurogenic DISEASE may_treat hyoscyamine sulfate MEDRT D001750 Urinary Bladder, Neurogenic DISEASE may_treat hyoscyamine MEDRT D014987 Xerostomia DISEASE induces hyoscyamine MEDRT D014987 Xerostomia DISEASE induces hyoscyamine sulfate MEDRT N0000000125 Cholinergic Muscarinic Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000125 Cholinergic Muscarinic Antagonists MOA has_moa hyoscyamine MEDRT N0000000207 Histamine Receptor Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000207 Histamine Receptor Antagonists MOA has_moa hyoscyamine MEDRT N0000000130 Serotonin Antagonists MOA has_moa hyoscyamine sulfate MEDRT N0000000130 Serotonin Antagonists MOA has_moa hyoscyamine MEDRT N0000008331 Cardiovascular Activity Alteration PE has_pe hyoscyamine sulfate MEDRT N0000008331 Cardiovascular Activity Alteration PE has_pe hyoscyamine MEDRT N0000008868 Decreased Respiratory Secretions PE has_pe hyoscyamine sulfate MEDRT N0000008868 Decreased Respiratory Secretions PE has_pe hyoscyamine
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.375 MG ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES QUANTITY 12 HR ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 NAMES Prescribable Synonym Levbid 0.375 MG 12HR Extended Release Oral Tablet SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon